Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide versus sitagliptin added to metformin in obese adults younger than 50 with type 2 diabetes
2008-007334-22Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Lixisenatide + metformin with Sitagliptin + metformin (2 arms). Primary endpoint: Composite glycemic and weight endpoint at week 24. Started Aug 2009; status: completed.
02
Drugs
lixisenatidesitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-007334-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007334-22.